Literature DB >> 24647256

Isolation of OXA-48 carbapenemase-producing Klebsiella pneumoniae ST101 from an overseas traveler returning to Japan.

Aki Hashimoto1, Maki Nagamatsu, Norio Ohmagari, Kayoko Hayakawa, Yasuyuki Kato, Teruo Kirikae.   

Abstract

OXA-48 carbapenemase-producing organisms have emerged rapidly worldwide and may be transmitted through patients who receive medical care abroad. To our knowledge, this is the second case of OXA-48-producing Klebsiella pneumoniae isolated from a patient who had returned to Japan after receiving treatment abroad.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24647256     DOI： 10.7883/yoken.67.120

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN： 1344-6304            Impact factor:   1.362


  4 in total

Review 1.  National Action Plan on Antimicrobial Resistance (AMR) 2016-2020 and relevant activities in Japan.

Authors:  Norio Ohmagari
Journal:  Glob Health Med       Date:  2019-12-31

2.  Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates.

Authors:  Sara Lomonaco; Matthew A Crawford; Christine Lascols; Ruth E Timme; Kevin Anderson; David R Hodge; Debra J Fisher; Segaran P Pillai; Stephen A Morse; Erum Khan; Molly A Hughes; Marc W Allard; Shashi K Sharma
Journal:  PLoS One       Date:  2018-06-08       Impact factor: 3.752

Review 3.  Travel-Related Antimicrobial Resistance: A Systematic Review.

Authors:  Hamid Bokhary; Krisna N A Pangesti; Harunor Rashid; Moataz Abd El Ghany; Grant A Hill-Cawthorne
Journal:  Trop Med Infect Dis       Date:  2021-01-16

Review 4.  Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods.

Authors:  Chang-Ro Lee; Jung Hun Lee; Kwang Seung Park; Young Bae Kim; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Microbiol       Date:  2016-06-13       Impact factor: 5.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.